BVF.SG - Bausch Health Companies Inc. Re

Stuttgart - Stuttgart Delayed Price. Currency in EUR
21.34
-0.29 (-1.34%)
At close: 7:55PM CEST
Stock chart is not supported by your current browser
Previous Close21.63
Open21.43
Bid0.00 x 100000
Ask0.00 x 100000
Day's Range21.31 - 21.44
52 Week Range9.45 - 24.51
Volume0
Avg. Volume286
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Analysts’ Recommendations for Valeant in June
    Market Realist4 months ago

    Analysts’ Recommendations for Valeant in June

    Valeant Pharmaceuticals (VRX) is one of the pharmaceutical companies that’s focused on developing and commercializing prescription pharmaceuticals, generic pharmaceuticals, over-the-counter products, and eye care products. Wall Street analysts expect revenues of ~$2.1 billion during the second quarter.

  • Reuters5 months ago

    Morning News Call Canadienne - Mai 8

    Pour consulter la lettre d'information; cliquez sur le lien: http://share.thomsonreuters.com/assets/newsletters/Morning_News_Call/MNCCA_FR_05082018.pdf PRINCIPAUX INDICATEURS À L’AGENDA 08:15 Mises en ...

  • InvestorPlace6 months ago

    Allergan plc Stock Looks Cheap for Good Reasons

    From a headline standpoint, Allergan plc (NYSE:AGN) stock does look attractive at the moment. A steady pullback has seen Allergan stock fall about 35% from late July highs and Allergan has dropped by half from 2015 levels. A sub-10x forward EPS multiple is notably cheaper than those assigned to rivals like Pfizer Inc. (NYSE:PFE) and Merck & Co., Inc. (NYSE:MRK).

  • 5 Big Biotech Stocks to Buy Under $10
    InvestorPlace7 months ago

    5 Big Biotech Stocks to Buy Under $10

    For investors, biotech stocks remain one of the most dynamic sectors out there. On one hand, you have some of the largest pharmaceutical firms on the planet with multi-billion-dollar blockbuster drugs filling their coffers. On the other, you have the more stereotypical “lotto ticket” biotech stocks of clinical or early production stage firms.

  • How Valeant Pharmaceuticals Intl Inc Can Give You a 750% Return
    InvestorPlace7 months ago

    How Valeant Pharmaceuticals Intl Inc Can Give You a 750% Return

    Valeant Pharmaceuticals Intl Inc (NYSE:VRX) still has its share of detractors. Late last month Valeant stock came out with its quarterly confessional, which featured an improving and profitable bottom-line of 98-cents-per-share.

  • Valeant Pharmaceuticals Intl Inc Stock Tumbles on Q4 Revenue Miss
    InvestorPlace8 months ago

    Valeant Pharmaceuticals Intl Inc Stock Tumbles on Q4 Revenue Miss

    Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock took a hit today following the release of its earnings report for the fourth quarter of 2017. The big blow to VRX stock today was the company’s revenue of $2.16 billion for the fourth quarter of the year. It also came in below Wall Street’s revenue estimate of $2.18 billion for the quarter.

  • InvestorPlace8 months ago

    Shopify Inc’s Problem Is It’s Still Not Making Money

    It shows revenues of $222.8 million, nearly double the previous year’s $130 million, and a gross profit of $121 million. During my reporting career, I have seen several Canadian companies rise, and then fall, on their own hype.